Managing Myeloma
- 2011-11-09 - New Review Looks At Treatment Strategies For Relapsed And Refractory Multiple Myeloma – Part 1: Retreatment With Novel Agents -- The Myeloma Beacon
- 2011-11-03 - Thalidomide Maintenance Therapy Fails To Provide Consistent Overall Survival Benefit -- The Myeloma Beacon
- 2011-11-03 - The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis -- Blood
- 2011-11-01 - FDA Approves Addition of Sustained Overall Survival Advantage (5-year follow-up) to Label for Bortezomib in Patients with Previously Untreated Multiple Myeloma -- Press Release MarketWatch/Business Wire
- 2011-10-31 - Beth Faiman MSN, CNP conducting research that examines over-the-counter drug's effect on chemotherapy side effects -- WKYC-TV
- 2011-10-31 - Study Finds Early And Delayed Stem Cell Transplants Have Comparable Efficacy In Newly Diagnosed Multiple Myeloma Patients -- The Myeloma Beacon
- 2011-10-31 - For the Treatment of Multiple Myeloma Hematologist-Oncologists Consider the Performance of Bortezomib More Favorably than Lenalidomide or Thalidomide Among the Most Important Attributes -- Press Release: BioTrends Research Group LLC
- 2011-10-26 - The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis - Blood
- 2011-10-26 - Therapeutic potential of CCR1 antagonists for multiple myeloma - Futurer Med Chem
- 2011-10-26 - Low-dose versus high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome (IFM) - Eur J Haematol
- 2011-10-26 - Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents - Leukemia
- 2011-10-25 - Experts Review Current And Future Research Into New Multiple Myeloma Treatments - The Myeloma Beacon
- 2011-10-21 - Prominent African-American studies scholar dies -- CNN
- 2011-10-21 - Nonsecretory Multiple Myeloma - The Myeloma Beacon
- 2011-10-20 - Nolan weathers cancer’s storms - Reporter/Vanderbilt UMC